NCT00645034View on ClinicalTrials.gov

A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

July 31, 2003

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG

placebo

placebo by mouth as a single dose

DRUG

sildenafil

sildenafil 100 mg by mouth as a single dose

Trial Locations (2)

92653

Pfizer Investigational Site, Laguna Woods

92660

Pfizer Investigational Site, Newport Beach

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00645034 - A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin | Biotech Hunter | Biotech Hunter